Opioid Review and MAT Clinic

Slides:



Advertisements
Similar presentations
EPS R2 Repeat Dispensing compared to typical repeat prescribing systems How it can benefit patients and practices...
Advertisements

Opioid Update F ederation of S tate M edical B oards Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain July 2013 F ederation.
Preventing Prescription Drug Abuse: Laws and Legislation Hollie Hendrikson, MSc Policy Specialist, Health Program.
Using the Maine PMP to Improve Prescribing Practices for Potentially Addictive Prescription Medications Susan Payne, MPH, PhD Research Professor Institute.
Community Opioid Addiction Program Tara McIntyre, Addiction/Mental Health Counsellor Megan Neill, Coordinator/Trainer of Specialized Programs.
Opioid Use in Work-related Injuries Pacific Northwest Chapter - Association of Occupational Health Professionals (AOHP) January 4, 2011 Jaymie Mai, PharmD.
Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.
Proposal for Supporting Academic Detailing on Safe Pain Medication Use for Utah Providers.
Study Finds Persons Who Fill Buprenorphine Prescriptions Have Higher Rates of Medical Conditions Associated with Pain and Comorbid Psychiatric Disorders.
Reducing Pain Medication Deaths in Utah: Physician Education and Practice Redesign Final Report by: HealthInsight June 2009.
Use of Opioids fro Chronic Pain in Primary Care Norman Wetterau MD
John Lipovsky, MPPM, AREM, PMM
Prescription Pain Med Program Utah Department of Health Presented by: Erin Johnson, MPH July 28, 2009 UDOH Public Health Informatics Brown Bag Seminar.
Sedative-hypnotic guideline, BHS
MAT-PDOA Program Evaluation Diana Seybolt, Ph.D. Karen McNamara, Ph.D. Systems Evaluation Center (SEC)
Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.
Implementing a Urine Drug Screening Protocol to Teach Appropriate Opioid Prescribing in a Residency Practice STFM Annual Conference May 2, 2016 Nata Young,
Medicated Assisted Treatment (MAT) Terry R. Jones Director of Behavioral Health.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
HOPE Agenda Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN – ASSEMBLY DISTRICT 89.
CDC Guideline for Prescribing Opioids for Chronic Pain- United States-2016 Gisele J. Girault, M.D. First Choice Healthcare Columbia, SC.
Medication Assisted Treatment
or you can use Text Voting by texting ”nmpha” to 22333
Wireless Access SSID: cwag2017
Access to Epinephrine for Self-Administration (EPI Rph)
OPIOID EPIDEMIC.
Jessica E. Bates, Pharm.D. PGY-1 Pharmacy Resident
Cover slide.
Electronic Repeat Dispensing (ERD)
Opioid Management in Primary Care Michael Parchman, MD, MPH
Partnership with Providers: Addressing the Opioid Crisis
THE OPIOID CRISIS Mississippi Board of Nursing
Nebraska Prescription Drug Overdose Prevention Program Efforts
Medication-Assisted Therapy at Coleman Profession Services
Caldwell County Narcotic Initiative
An overdose Reduction PlaN
Opioids in chronic pain
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Hannah K. Knudsen, Jennifer R. Havens, Michelle R. Lofwall, Jamie L
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Opioid Crisis A Call to ACTION
An Overview of the ePDMP
Prescription Drug Monitoring Program Facts, Figures, and Trends 3rd Quarter 2017 North Dakota Board of Pharmacy Kathy Zahn, CPhT, PDMP Program Administrator.
ROOM project Addressing the Opioid Epidemic in the U.P.
Buccaneers SAIL Safe Accountable In Control Lead by Example.
Opioid Prescribing & Monitoring
Key Performance Indicators
Barbara Allison-Bryan, MD
DATA 2000 Waivers The Drug Addiction Treatment Act of 2000 (DATA 2000) permits physicians who meet certain qualifications to treat opioid dependency with.
Eric Weintraub MD University of Maryland, School of Medicine
Opioids in Butte County
Prescription Drug Monitoring Program
Using Data to Combat the Opioid Overdose Crisis
Mat in a tribal health clinic
Prescription Drug Monitoring Program
Overcoming Barriers to Opioid Use Disorder Treatment in Rural Areas
Illinois Prescription Monitoring Program
Outpatient Chart Flow “To call” Pile
Academic Detailing (AD): A New Resource From AR-IMPACT
PMP Advisory Committee
2018 Prescription Nation Report
Recognition of Opioid Overdose
Flowchart for Falls Referral
Data Sources ADH: Other AR Data: National: Vital Statistics PDMP
Medication Assisted Treatment of Opioid Use Disorder
The Silent Killer in America
Presentation transcript:

Opioid Review and MAT Clinic Data Collection January 3, 2018

“To fear change is to fear being challenged “To fear change is to fear being challenged. To fear being challenged is to fear growth and new possibilities.”

ECHO

Goals of the Opioid Review and MAT Clinic ECHO Aid providers in the appropriate management of narcotic prescribing. Give providers the ability to identity patients that are not appropriate for opioids, through things such as chart reviews.  Be able to identify comorbidities that put patients at higher risk of death. Collect data for the state that will demonstrate that we can improve prescribing practices and decrease the number of pills being prescribed.  Increase the number of buprenorphine providers in rural Minnesota. Educate physicians on the CDC and state guidelines.

Data We Want to Collect How many patients have had their controlled substances discontinued (this you will begin tracking as the program progresses). Why were they discontinued, how many pills per month, per year How many patients have received 5 or more opioid prescriptions in the last 12 rolling months- this can be collected through the EMR Number of patients on Suboxone (we understand some may not have any Suboxone patients at this time) Number of opioid overdoses in your county, and if possible, the Narcan use in your ambulance services. (If you are able to obtain this data)

Data We Want to Collect A list of patients on controlled substances. We only need to know the numbers for your clinic. Contact the main pharmacy in town and obtain data on the number of prescriptions of controlled substance opioid pills being dispensed per month, as a baseline piece of information.  How many patients have controlled substance agreements on file.